Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If approved by the European Commission (EC), atogepant will be the first and only once daily oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) in the European Union (EU) for the prophylaxis of migraine in adults who have four or m...
Although second-generation antihistamines are preferred, patient preference should drive selection of therapy.
Despite alarming figures and trends, public awareness of alcohol as a carcinogen remains low.
The arrival of the Enhancing Oncology Model has renewed the uncertainties surrounding value-based care approaches for practices opting into the next wave of Center for Medicare & Medicaid Services performance structure
PHILADELPHIA--(BUSINESS WIRE)--Jun 21, 2023--